| P2093 | author name string | Hyun Joo Song | |
| | Seung Uk Jeong | |
| | Sun-Jin Boo | |
| | Hyeyoung Jwa | |
| | Byung-Cheol Song | |
| | Eun Kwang Choi | |
| | Heung Up Kim | |
| | Yoo-Kyung Cho | |
| | Soo-Young Na | |
| P2860 | cites work | Serologic and clinical outcomes of 1536 Alaska Natives chronically infected with hepatitis B virus | Q45734895 |
| | Spontaneous reactivation of chronic hepatitis B virus infection. | Q45794787 |
| | Spontaneous hepatitis B e antigen to antibody seroconversion and reversion in Chinese patients with chronic hepatitis B virus infection | Q45830698 |
| | Intrahepatic distribution of hepatitis B surface and core antigens in chronic hepatitis B virus infection. Hepatocyte with cytoplasmic/membranous hepatitis B core antigen as a possible target for immune hepatocytolysis. | Q45830903 |
| | Acute exacerbations in Chinese patients with chronic hepatitis B virus (HBV) infection. Incidence, predisposing factors and etiology | Q45849476 |
| | Clinical, virologic and histologic outcome following seroconversion from HBeAg to anti-HBe in chronic hepatitis type B | Q70030183 |
| | Clinical and histological events preceding hepatitis B e antigen seroconversion in chronic type B hepatitis | Q71727736 |
| | Genotype C hepatitis B virus infection is associated with a higher risk of reactivation of hepatitis B and progression to cirrhosis than genotype B: a longitudinal study of hepatitis B e antigen-positive patients with normal aminotransferase levels | Q80351072 |
| | Sustained disease remission after spontaneous HBeAg seroconversion is associated with reduction in fibrosis progression in chronic hepatitis B Chinese patients | Q80752603 |
| | Clearance of hepatitis B e antigen in patients with chronic hepatitis B and genotypes A, B, C, D, and F | Q81404746 |
| | Long-term treatment with entecavir induces reversal of advanced fibrosis or cirrhosis in patients with chronic hepatitis B | Q82822290 |
| | EASL clinical practice guidelines: Management of chronic hepatitis B virus infection | Q29615868 |
| | Chronic hepatitis B. | Q34002160 |
| | Predictive factors for reactivation of hepatitis B following hepatitis B e antigen seroconversion in chronic hepatitis B. | Q34007571 |
| | Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures | Q34302587 |
| | Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B: a 5-year open-label follow-up study | Q34317204 |
| | Lamivudine for patients with chronic hepatitis B and advanced liver disease | Q34551713 |
| | A large population study of spontaneous HBeAg seroconversion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. | Q35595459 |
| | Acute exacerbations of chronic type B hepatitis are accompanied by increased T cell responses to hepatitis B core and e antigens. Implications for hepatitis B e antigen seroconversion | Q35596038 |
| | Classifying hepatitis B virus genotypes | Q35612659 |
| | Asian-Pacific consensus statement on the management of chronic hepatitis B: a 2012 update | Q35706189 |
| | KASL Clinical Practice Guidelines: Management of chronic hepatitis B. | Q36153966 |
| | Hepatitis B virus genotype C prevails among chronic carriers of the virus in Korea | Q37425698 |
| | Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the study of the liver (APASL). | Q37577568 |
| | Mortality, liver transplantation, and hepatocellular carcinoma among patients with chronic hepatitis B treated with entecavir vs lamivudine. | Q42234528 |
| | Long-term entecavir therapy results in the reversal of fibrosis/cirrhosis and continued histological improvement in patients with chronic hepatitis B. | Q42947269 |
| | Hepatitis B virus DNA level predicts hepatic decompensation in patients with acute exacerbation of chronic hepatitis B. | Q43124994 |
| | Entecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosis | Q43565728 |
| | Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B. | Q44005581 |
| | Hepatitis B virus genotype B is associated with earlier HBeAg seroconversion compared with hepatitis B virus genotype C. | Q44021728 |
| | Long-term entecavir treatment reduces hepatocellular carcinoma incidence in patients with hepatitis B virus infection | Q44323346 |
| | Hepatitis B virus genotypes and spontaneous hepatitis B e antigen seroconversion in Taiwanese hepatitis B carriers | Q44745645 |
| | Predictive factors for early HBeAg seroconversion in acute exacerbation of patients with HBeAg-positive chronic hepatitis B. | Q45071417 |
| | Hepatitis B virus genotypes in Korea: an endemic area of hepatitis B virus infection | Q45487012 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 4 | |
| P921 | main subject | seroconversion | Q2141450 |
| | chronic hepatitis B | Q55779876 |
| P304 | page(s) | 355-360 | |
| P577 | publication date | 2014-12-24 | |
| P1433 | published in | Clinical and molecular hepatology | Q26853927 |
| P1476 | title | Is it necessary to delay antiviral therapy for 3-6 months to anticipate HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B in endemic areas of HBV genotype C? | |
| P478 | volume | 20 | |